Funny, I'm having this problem too. However,
Post# of 148187
However, CytoDyn's clinical trial, FDA approval, and time-to-market timelines are allowing me to still analyze short and medium term opportunities.
But I do find myself thinking that some of these companies/drugs might be decimated by leronlimab.